Pfizer has requested Well being Canada to approve the primary COVID-19 vaccine for youngsters aged 5 to 11 years previous.
As quickly because the regulator offers the inexperienced mild, suppliers will be capable of begin providing the COVID-19 shot to youngsters, although new child-sized doses would possibly have to be procured.
‘Dad and mom are asking all the correct questions,’ as COVID-19 vaccine for youths awaits approval: professional
The doses are about one-third the scale given to adults and youths age 12 and up.
The vaccine was developed in partnership with Germany’s BioNTech and is now marketed underneath the model identify Comirnaty. It was approved for individuals at the very least 16 years previous final December, and for youths between 12 and 15 in Could.
Pfizer already submitted medical trial knowledge for its child-sized dose to Well being Canada firstly of the month, and made a proper request for approval to the U.S. Meals and Drug Administration final week.
The Pfizer-BioNTech vaccine has additionally been examined on kids as younger as six months previous. Topline knowledge for youngsters underneath 5 years previous is anticipated as quickly as the top of the 12 months.
View hyperlink »
© 2021 The Canadian Press